Feed BAYN.DE
BA

Bayer AG

BAYN.DE · XETRA

47.89 € -1.66% (-0.81 €)
1M +0.23%
Market Cap 47.9B €
P/E Ratio -
Div. Yield 0.23%
ROE 6.10%

Bulios Fair Price

35.12 €

26.7% downside

Trenutna cena

47.89 €

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica BAYN.DE trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Weak
3/9
Valuation
56 /100
Fair
EV/EBITDA 16.16x
P/S 1.06x
P/B 1.62x
Growth
1 /100
Declining
Rev. growth 3.51%
FCF growth 20.48%
Book val. growth 12.53%
Profitability
45 /100
Moderate
Gross margin 59.05%
Net margin 3.83%
Op. margin 13.67%
Quality
28 /100
Poor
ROIC 10.56%
ROE 6.10%
ROA 1.62%
Debt
20 /100
High
Debt/Equity 1.30x
Current ratio 1.04x
Int. coverage 0.52x
Stability
56 /100
Moderate
Beta 0.83x
Rev. volatility 2.27%
EPS volatility 94.45%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o BAYN.DE
Online

O podjetju

Bayer AG (BAYN) is a German multinational company operating in the fields of pharmaceuticals, agriculture, and chemicals. In the pharmaceutical sector, Bayer manufactures drugs for various therapeutic areas, including cardiology, dermatology, and oncology. In the agricultural sector, Bayer focuses on the development and sale of pesticides, fertilizers, and seed technologies to increase yields and protect crops. In the chemical sector, the company produces a wide range of chemical products for industrial and consumer markets. Bayer is known for its focus on innovation and research and has a strong international presence. Shares of Bayer AG (BAYN) may be suitable for investors seeking a diversified investment in the pharmaceutical, agricultural, and chemical industries with international reach.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Bill Anderson

Employees

87,830

Headquarters

Leverkusen

Prihajajoči dogodki

03 NOV.

Earnings

Upcoming earnings report

52d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.